...
首页> 外文期刊>International journal of molecular medicine >Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis
【24h】

Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates microbiota dysbiosis in an experimental model of sepsis

机译:Lactobacillus rhamoosus Gg治疗改善了肠道渗透性,并在败血症的实验模型中调节微生物群脱皮病

获取原文

摘要

Decrease of ‘health?benefiting’ microbes and increase of pathogenic bacteria (a condition termed dysbiosis) in intensive care unit patients is considered to induce or aggravate sepsis (gut?origin sepsis). Orally administered probiotics have been effective in the prevention of nosocomial infections. However, the mechanisms of probiotic?induced anti?infection and anti?sepsis remain to be explored. In the present study, 4?week?old C57BL6 mice were orally administrated with Lactobacillus rhamnosus GG (LGG) or normal saline (control) 4 weeks prior to cecal ligation and puncture (CLP). A subset of the mice were sacrificed at 24 h post?CLP, and the others were used for survival studies. Ileum tissues, blood and fecal samples were collected. The survival rate of septic mice pretreated with LGG was significantly improved compared with untreated mice. The levels of inflammatory cytokines were reduced in LGG?pretreated septic mice. A decrease of colonic proliferation and epithelial tight junctions and an increase of colonic apoptosis were observed in control septic CLP+saline mice. LGG pretreatment reversed the colonic proliferation, apoptosis and expression of tight junction proteins to the levels of the sham group. LGG pretreatment improved the richness and diversity of intestinal microbiota in septic mice. The principal coordinates analysis clustering plots revealed a significant separate clustering in microbiota structure between three groups. Bacteria associated with energy consumption, including Bacteroidetes, with opportunistic infection, including Proteobacteria, Staphylococcaceae and Enterococcaceae, lipopolysaccharide producers, including Enterobacteriaceae, and facultative anaerobes, such as Bacteroidaceae and Erysipelotrichaceae, increased in septic mice. By contrast, bacteria associated with energy harvest, including Firmicutes, intestinal barrier function regulators, including Akkermansia, hepatic function regulators, including Coprococcus and Oscillospira, and obligate anaerobes, including Prevotellaceae, decreased in septic mice. With LGG pretreatment, the sepsis?induced microbiota dysbiosis was reversed. The present results elucidated the potential mechanism of LGG treatment in sepsis, by improving intestinal permeability and modulating microbiota dysbiosis.
机译:“健康”减少?受益于密集护理单元患者的微生物和致病细菌的增加(病症被称为呼吸困难)诱导或加重败血症(肠道肠脓毒症)。口服给药的益生菌在预防医院感染方面都是有效的。然而,益生菌的机制?诱导抗α感染和抗蛋白酶仍有待探索。在目前的研究中,4个?每周?旧C57BL6小鼠在术前4周之前用乳酸杆菌菌菌菌菌菌(LGG)或生理盐水(对照)4周给予康复和穿刺(CLP)。在24小时后处死小鼠的一部分小鼠的子集合,而其他小鼠的子集合用于存活研究。收集回肠组织,血液和粪便样品。与未处理的小鼠相比,用LGG预处理的脓化小鼠的存活率显着改善。炎症细胞因子的水平降低了LGG?预处理的化粪池小鼠。在对照化脓性CLP +盐小鼠中观察到结肠增殖和上皮紧密交界和上皮紧密交界的降低以及结肠细胞凋亡的增加。 LGG预处理逆转了严重结蛋白的结肠增殖,细胞凋亡和表达的假手术蛋白。 LGG预处理改善了肠碎鼠中肠道微生物群的丰富性和多样性。主坐标分析聚类局部揭示了三组之间微生物群结构中显着的单独聚类。与能量消耗相关的细菌,包括拟机械感染,包括促菌菌,葡萄球菌和肠球菌,脂多糖生产商,包括肠杆菌酸和肠杆菌和兼脓疱疮和嗜酸剂脂肪酸的兼性Anaerobeae,在脓菌老鼠中增加。相比之下,与能量收获有关的细菌,包括肠道障碍功能调节剂,包括Akkermansia,肝功能调节剂,包括泛球菌和散形血管,并且在包括PREMOTELLACEA的厌氧菌中的厌氧菌减少。用LGG预处理,败血症?诱导的微生物瘤功能消化逆转。通过改善肠道渗透性和调节微生物菌脱敏症,阐明了本发明的结果阐明了败血症中LGG治疗的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号